$RCKT News Article - Rocket Pharmaceuticals Announces Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301 for the Treatment of Pyruvate Kinase Deficiency https://marketwirenews.com/news-releases/rock...06414.html
(0)
(0)
Rocket Pharmaceuticals, Inc. (RCKT) Stock Research Links